The Government of Canada, through the Canadian Institutes of Health Research, is providing $6M to the Canadian Network of COVID-19 Clinical Trials Networks to support Canada’s continued response to the rapidly evolving COVID-19 pandemic.
Led by Dr. Robert Fowler at the Sunnybrook Research Institute in Toronto, the network will support trials that treat severe COVID illness for patients in the intensive care unit and in hospitals, that aim to prevent illness among the population, and that help Canadians and their families recover from COVID-related illness. It will do so by expanding existing national and international clinical trial networks to coordinate research on interventions to prevent, detect, manage, and treat COVID-19.
More specifically, it will:
- engage citizens and patients;
- help set research priorities involving the public and private sectors;
- facilitate collaboration and resource sharing;
- work with Canadian and global partners to reduce duplication;
- simplify research regulatory steps;
- connect data from many clinical trials; and
- provide evidence to decision-makers for clinical and health system management and public health response across the country and internationally.
With its diverse and inclusive partnership, the network will not only mobilize knowledge and maximize research impact, but also build research capacity and better prepare us for future pandemics.
The Canadian Critical Care Trials Group is supporting this network of COVID trials networks. The network is partnering with more than 40 networks, groups, and institutions across Canada.